TNF and inflammation: A decrease in TNFα was consistently observed over each 6-hour treatment period (A, B, and C), achieving significance at p = 0.0022 when all SCD treatment periods A–C were combined (n = 9) and providing strong evidence that the SCD Rx course reduced the chronic systemic inflammation associated with MetS as presented in this model (Figure 5).